AEON Biopharma (AEON) Short Interest Ratio & Short Volume

Short interest is the volume of AEON Biopharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 176,600 shares of AEON short. 1.67% of AEON Biopharma's shares are currently sold short. Learn More on AEON Biopharma's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.67% of AEON Biopharma's floating shares are currently sold short.

AEON Biopharma saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 176,600 shares, an increase of 156.3% from the previous total of 68,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

AEON Biopharma currently has issued a total of 11,305,000 shares. Some of AEON Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AEON Biopharma currently has a public float of 10,560,000 shares.

1.67% of AEON Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to AEON Biopharma: NanoViricides, Inc. (0.44%), Tempest Therapeutics, Inc. (3.80%), Cara Therapeutics, Inc. (1.74%), Cyclo Therapeutics, Inc. (3.55%), Lisata Therapeutics, Inc. (0.35%), MIRA Pharmaceuticals, Inc. (3.63%), Relmada Therapeutics, Inc. (4.93%), NeuroSense Therapeutics Ltd. (1.67%), CASI Pharmaceuticals, Inc. (0.31%), CalciMedica, Inc. (2.05%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling AEON is an investing strategy that aims to generate trading profit from AEON Biopharma as its price is falling. AEON shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for AEON Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AEON, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AEON, twice per month. The most recent reporting period available is May, 15 2025.